Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × Resectable NSCLC × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1407 Neoplasms 1128 Prostatic Neoplasms 745 Lung Neoplasms 620 Colorectal Neoplasms 595 Carcinoma, Non-Small-Cell Lung 567 Carcinoma, Hepatocellular 415 Pancreatic Neoplasms 405 Leukemia, Myeloid, Acute 388 Stomach Neoplasms 356 Multiple Myeloma 317 Ovarian Neoplasms 306 Brain Neoplasms 303 Head and Neck Neoplasms 288 Neoplasm Metastasis 271 Precursor Cell Lymphoblastic Leukemia-Lymphoma 263 Rectal Neoplasms 258 Uterine Cervical Neoplasms 251 Esophageal Neoplasms 247 Melanoma 243 Recurrence 240 Glioblastoma 224 Squamous Cell Carcinoma of Head and Neck 220 Sarcoma 211 Lymphoma 211 Colonic Neoplasms 200 Urinary Bladder Neoplasms 192 Glioma 188 Hematologic Neoplasms 182 Triple Negative Breast Neoplasms 180

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492342 2026-03-25

K-NADIR

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡